People in the News
William Emhiser has been appointed as new chief executive of Whatman, the company said last week. He replaces Timothy Haines, who was named chief executive in May. Emhiser will take up his appointment on Nov. 1. He is currently president of North American operations for Proteome Systems. Prior to that, he held a number of senior management positions at Millipore. Emhiser holds a degree in biomedical engineering from Duke University.
Murray Wigmore has joined GE Healthcare Canada as general manager for the clinical systems group. Previously, he was senior vice president at MDS Sciex.
New Product Watch
Expression Analysis said last week that it has developed a new two-group comparison analysis for differential expression called permutation analysis for differential expression, or PADE.
The tool will enable researchers to detect and estimate changes in expression between two experimental groups of three or more samples. EA recommended PADE for experimental designs that involve a baseline group and an experimental group such as control vs. treated, negative vs. positive, mutant vs. wild-type, or any two conditions from a multi-condition experiment.
Gene Logic recently launched its Microarray Data Generations and Analysis services labs.
According to a statement, the services offered include gene expression data generation from tissue, cells, blood, or RNA; optimized gene expression profiling of whole blood using Gene Logic's protocol to reduce globin interference; RNA isolation from low-yield tissues or samples that are difficult to process; custom bioinformatics analysis for biomarker or drug target identification and mechanisms of toxicity; custom platform development; and SNP genotyping from DNA, blood, or tissue.